On February 23, 2013 the FDA released notice of a voluntary, nationwide recall of Omontys. Affymax has voluntarily initiated a recall of its Omontys injectible medication. Omontys treats anemia which results from chronic kidney disease. The recall was being done with the knowledge of the FDA and all health care providers are notified to stop using or further prescribing the medication until further notice. After the drug was cleared and released to the market, a seemingly sma